The Pennant Group, Inc. (NASDAQ:PNTG) Receives $41.60 Consensus Price Target from Brokerages

by · The Markets Daily

The Pennant Group, Inc. (NASDAQ:PNTG – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eight brokerages that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $41.60.

A number of equities analysts recently commented on PNTG shares. Wall Street Zen raised The Pennant Group from a “hold” rating to a “buy” rating in a research note on Saturday, June 20th. Truist Financial upped their price objective on The Pennant Group from $42.00 to $48.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Wells Fargo & Company increased their target price on The Pennant Group from $45.00 to $46.00 and gave the company an “overweight” rating in a research report on Tuesday, August 11th. Weiss Ratings raised shares of The Pennant Group from a “buy (b-)” rating to a “buy (b)” rating in a report on Wednesday, August 19th. Finally, Royal Bank Of Canada boosted their price target on shares of The Pennant Group from $42.00 to $44.00 and gave the stock an “outperform” rating in a research report on Thursday, August 20th.

Check Out Our Latest Stock Report on The Pennant Group

The Pennant Group Stock Performance

PNTG opened at $39.62 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.20 and a current ratio of 1.20. The stock has a market capitalization of $1.38 billion, a price-to-earnings ratio of 44.02, a PEG ratio of 2.58 and a beta of 1.27. The company has a fifty day moving average of $39.51 and a 200 day moving average of $35.41. The Pennant Group has a fifty-two week low of $22.25 and a fifty-two week high of $42.74.

The Pennant Group (NASDAQ:PNTG – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.36 EPS for the quarter, topping the consensus estimate of $0.33 by $0.03. The business had revenue of $297.98 million for the quarter, compared to analysts’ expectations of $288.71 million. The Pennant Group had a net margin of 2.93% and a return on equity of 10.33%. The Pennant Group has set its FY 2026 guidance at 1.340-1.410 EPS. As a group, sell-side analysts forecast that The Pennant Group will post 1.18 earnings per share for the current fiscal year.

Institutional Trading of The Pennant Group

Large investors have recently made changes to their positions in the business. Rice Hall James & Associates LLC purchased a new position in The Pennant Group in the second quarter worth about $9,241,000. Sei Investments Co. raised its position in The Pennant Group by 33.7% during the first quarter. Sei Investments Co. now owns 153,546 shares of the company’s stock valued at $4,680,000 after purchasing an additional 38,735 shares during the period. Manatuck Hill Partners LLC bought a new stake in shares of The Pennant Group in the 2nd quarter valued at approximately $2,217,000. Vanguard Group Inc. lifted its stake in shares of The Pennant Group by 4.2% in the 4th quarter. Vanguard Group Inc. now owns 2,049,968 shares of the company’s stock valued at $57,707,000 after purchasing an additional 82,071 shares during the last quarter. Finally, Deutsche Bank AG purchased a new position in shares of The Pennant Group in the 2nd quarter worth approximately $5,132,000. 85.88% of the stock is currently owned by institutional investors.

The Pennant Group Company Profile

(Get Free Report)

The Pennant Group, Inc is a healthcare services company that operates home health, hospice and personal care businesses, as well as senior living communities. Its services are designed to support older adults and other patients in their homes, residential settings and communities, with offerings that may include skilled nursing, therapy, hospice care, assisted living and memory care.

The company serves patients and residents through a network of affiliated operating companies and communities across multiple U.S.

See Also